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Abstract  
AIM: To investigate the effect of bariatric surgery on HbA1c and serum cortisol levels in morbidly obese patients 
without type 2 diabetes mellitus.  
MATERIALS AND METHODS: Twenty-nine patients who underwent sleeve gastrectomy and whose body mass 
index was> 40 were included in the present study. Patients' files were reviewed retrospectively. Those with 
diabetes mellitus and those with age <18 were excluded from the study. Pre-operative and 1-year post operative 
data were documented. The obtained data were analysed by SPSS statistical program.
 
RESULTS: The mean age of the patients was 27.4 ± 8.4. 5 of the patients were male, and 24 were female. The 
mean body mass index of the patients was 44 ± 2.3. 1 patient [3.4%] had hypertension. Four patients [13.7%] had 
gastroesophageal reflux disease. The number of smokers was 7 [24.1%], and the number of alcohol users was 3 
[10.3%]. There was a statistically significant decrease in HbA1c, body mass index values after operation [p value 
<0.01], but cortisol was not different [p value = 0.72].  
CONCLUSION: In this present study we found that bariatric surgery caused a significant decrease in HbA1c 
levels in non-diabetic patients, suggesting that bariatric surgery may prevent Type 2 Diabetes Mellitus in obese 
patients. 
 
 
 
 
 
 
Introduction 
 
Type 2 diabetes mellitus is a preventable 
disease. With an appropriate and effective exercise 
and diet program, this disease can be prevented [1]. 
In the development of Type 2 DM, it is thought that the 
starting point is insulin resistance [2-3]. It is known 
that the process leading to insulin resistance is 
excessive weight gain. 
In overweight diabetic patients who do not 
respond to medical treatments and lifestyle changes, 
bariatric surgery has become a very important option 
today [4-8]. Here, we hypothesise that weight loss 
after a sleeve gastrectomy can break insulin 
resistance and prevent Type 2 DM development. To 
support this hypothesis, we examined the effect of 
sleeve gastrectomy on HbA1c in patients without type 
2 diabetes mellitus.
 
Materials and Methods 
 
Twenty-nine patients who underwent Sleeve 
gastrectomy in Adiyaman University Medical Faculty 
Education Research Hospital and whose body mass 
index was 40 were enrolled in this present study. 
Patients' files were reviewed retrospectively. Those 
with type 2 diabetes mellitus, those with malignancy or 
collagen tissue disease, those using corticosteroids 
and those with age <18 were excluded from the study. 
Age, gender, body mass index, the presence of 
additional illness, smoking, alcohol use, serum HbA1c 
and cortisol levels were recorded before the 
operation. Body mass index (BMI) and cortisol levels 
were re-evaluated at the first postoperative year.
 
All the analyses were done using the SPSS 
for Windows [version 21.0; SPSS / IBM, Chicago, IL]. 
Descriptive statistics and paired samples were used 
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when suitable. The statistical significance level was 
accepted as a P value of less than 0.05.
 
 
 
Results 
 
The mean age of the patients was 27.4 ± 8.4. 
5 of the patients were male, and 24 were female. The 
mean body mass index of the patients was 44 ± 2.3. 1 
patient [3.4%] had hypertension. Four patients 
[13.7%] had gastroesophageal reflux disease. The 
number of smokers was 7 [24.1%], and the number of 
alcohol users was 3 [10.3%]. One [3.4%] patient 
underwent cholecystectomy due to cholecystitis. The 
demographic and general characteristics of the 
patients are summarised in Table 1. 
 
Table 1: General characteristics of patients 
Parameters N = 29 
Age 27.4 ± 8.4 
Gender Male / Female 5/24 (17.2%/82.8%) 
Hypertension  1 (3.4%) 
Cholecystitis  1 (3.4%) 
Smoking 7 (24.1%) 
Alcohol consumption 3 (10.3%) 
Reflux disease 4 (13.7%) 
Body Mass Index 44 ± 2.3 
Cortisol 13.6 ± 2.7 
 
There was a statistically significant decrease 
in HbA1c, body mass index values after operation [p 
values <0.01, <0.01], but cortisol was not different [p 
value = 0.72]. The mean preoperative HbA1c value 
was 4.4 ± 0.6, but it decreased to 3.94 ± 0.5 in the first 
year after operation. The mean BMI before the 
operation was 44 ± 2.3 and it decreased to 28 ± 3.1 in 
the first year after operation. The mean cortisol level 
before surgery was 13.6 ± 2.7 and 13.6 ± 3.6 at 1 year 
after operation. The values of the patients before and 
after the operation are summarised in Table 2.
 
Table 2: Comparison of preoperative and postoperative values 
of patients 
Parameters Preoperative Postoperative P values 
HBA1C 4.4 ± 0.6 3.94 ± 0.5 <0.01 
Cortisol 13.6 ± 2.7 13.6 ± 3.6 0.81 
Body Mass Index 44 ± 2.3 28 ± 3.1 <0.01 
 
 
Discussion 
 
Morbid obesity is a preventable and treatable 
disease that sets the stage for many diseases. 
Depending on the metabolic and endocrinological 
effects of obesity, type 2 diabetes mellitus [DM], 
dyslipidemia, hypertension, cardiovascular diseases, 
gastroesophageal reflux disease, degenerative joint 
disease, cholelithiasis, hepatosteatosis and some 
types of cancer may develop [9-15]. With weight loss, 
most of these illnesses can heal or can get out of 
hand. 
Bariatric surgery has become a very important 
option in the overweight problem of not responding to 
medical treatments and lifestyle changes. Sleeve 
gastrectomy is one of the bariatric surgical methods. 
Sleeve gastrectomy is a partial gastrectomy, in which 
the majority of the stomach is removed. Restricted 
food intake and hormonal changes in hunger and 
insulin resistance lead to the weight loss. Thus, high 
rates of short-term improvement in type 2 diabetes 
mellitus and insulin resistance, leading to overweight, 
are achieved. 
Many studies in the literature have shown that 
the bariatric surgery provides a high rate of 
improvement in DM patients [16-20]. According to our 
knowledge, we did not find a study that examines the 
change in HbA1c levels in non-diabetic patients with 
bariatric surgeries. For this reason, we retrospectively 
reviewed our patients who did not have diabetes 
mellitus, thinking that the bariatric surgery could be 
effective in preventing diabetes even in the absence 
of diabetes mellitus. 
The mean HbA1c value of our patients before 
surgery was 4.4 ± 0.6, and decreased to 3.94 ± 0.5 at 
1 year after operation [p value < 0.01]. Thus, the 
obvious precaution in the preventive medicine of the 
bariatric surgery emerges. In lifestyle modification and 
obese patients who do not respond to 
pharmacological treatment, bariatric surgery will 
prevent many diseases that can be caused by obesity. 
This surgical method, which has very successful 
results in well-selected patient groups, will significantly 
improve countries' health spending. 
It is known that there is a slight increase in the 
level of cortisol in obese patients. We studied the 
effect of weight loss on cortisol in our study. The 
mean cortisol level before surgery was 13.6 ± 2.7 and 
13.6 ± 3.6 at 1 year after operation [p value = 0.81]. 
There was no significant decrease in cortisol levels in 
our study. 
The limitations of our work were: 1. The 
number of the patients was low; 2. The study design 
was retrospective; and 3. The follow-up time was as 
short as 1 year. 
Studies conducted with surveillance covering 
too many and very long years can reveal this 
relationship more clearly. 
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